Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review

  • ID: 4285246
  • SWOT Analysis
  • 43 pages
  • GlobalData
  • Alder BioPharmaceuticals Inc
1 of 5

FEATURED COMPANIES

  • Abeona Therapeutics Inc
  • Celgene Corp
  • MORE
Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection system and novel mab xpress antibody production system. Its pipeline products include clazakizumab and eptinezumab. Alder’s clazakizumab is a novel monoclonal antibody used for the treatment of rheumatoid arthritis and psoriatic arthritis. The company’s eptinezumab is an investigational product candidate for migraine prevention treatment for patients with chronic and frequent episodic migraine. Alder is headquartered in Bothell, Washington, the US.

Alder Biopharmaceuticals Inc Key Recent Developments

Nov 07, 2017: Alder BioPharmaceuticals Announces Third Quarter 2017 Financial and Operating Results
Aug 08, 2017: Alder BioPharmaceuticals Announces Second Quarter 2017 Financial and Operating Results
Apr 27, 2017: Alder BioPharmaceuticals Announces First Quarter 2017 Financial and Operating Results
Apr 04, 2017: Alder BioPharmaceuticals Appoints Wendy L. Yarno to its Board of Directors
Feb 23, 2017: Alder BioPharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial and Operating Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abeona Therapeutics Inc
  • Celgene Corp
  • MORE
Section 1 - About the Company
  • Alder Biopharmaceuticals Inc - Key Facts
  • Alder Biopharmaceuticals Inc - Key Employees
  • Alder Biopharmaceuticals Inc - Key Employee Biographies
  • Alder Biopharmaceuticals Inc - Major Products and Services
  • Alder Biopharmaceuticals Inc - History
  • Alder Biopharmaceuticals Inc - Company Statement
  • Alder Biopharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Alder Biopharmaceuticals Inc - Business Description
  • Alder Biopharmaceuticals Inc - Corporate Strategy
  • Alder Biopharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Alder Biopharmaceuticals Inc - Strengths
  • Alder Biopharmaceuticals Inc - Weaknesses
  • Alder Biopharmaceuticals Inc - Opportunities
  • Alder Biopharmaceuticals Inc - Threats
  • Alder Biopharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Alder Biopharmaceuticals Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Nov 07, 2017: Alder BioPharmaceuticals Announces Third Quarter 2017 Financial and Operating Results
  • Aug 08, 2017: Alder BioPharmaceuticals Announces Second Quarter 2017 Financial and Operating Results
  • Apr 27, 2017: Alder BioPharmaceuticals Announces First Quarter 2017 Financial and Operating Results
  • Apr 04, 2017: Alder BioPharmaceuticals Appoints Wendy L. Yarno to its Board of Directors
  • Apr 04, 2017: Alder BioPharmaceuticals Appoints Wendy L. Yarno to its Board of Directors
  • Feb 23, 2017: Alder BioPharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial and Operating Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Alder Biopharmaceuticals Inc, Key Facts
  • Alder Biopharmaceuticals Inc, Key Employees
  • Alder Biopharmaceuticals Inc, Key Employee Biographies
  • Alder Biopharmaceuticals Inc, Major Products and Services
  • Alder Biopharmaceuticals Inc, History
  • Alder Biopharmaceuticals Inc, Subsidiaries
  • Alder Biopharmaceuticals Inc, Key Competitors
  • Alder Biopharmaceuticals Inc, Ratios based on current share price
  • Alder Biopharmaceuticals Inc, Annual Ratios
  • Alder Biopharmaceuticals Inc, Annual Ratios
  • Alder Biopharmaceuticals Inc, Interim Ratios
  • Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Alder Biopharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Alder Biopharmaceuticals Inc, Performance Chart (2012 - 2016)
  • Alder Biopharmaceuticals Inc, Ratio Charts
  • Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Teva Pharmaceuticals USA Inc
  • Merrimack Pharmaceuticals Inc
  • Celgene Corp
  • Abeona Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll